Figure 2From: Early clinical experience with volumetric modulated arc therapy in head and neck cancer patientsFirst row: average (over all patients) DVH for CTV and PTV high dose, with 1SD as dotted lines. Second row: average (divided for groups A and B) DVH for CTV and PTV low dose, with 1SD as dotted lines.Back to article page